Cargando…
Use of Diagnostic Tests in Advanced Non–Small Cell Lung Cancer
INTRODUCTION As the official publication of the Advanced Practitioner Society for Hematology and Oncology (APSHO), JADPRO is pleased to offer Part 1 of an accredited educational activity based on the recently concluded APSHO Regional Lecture Series. Hosted in collaboration with major cancer centers...
Autor principal: | Eaby-Sandy, Beth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995493/ https://www.ncbi.nlm.nih.gov/pubmed/29900025 |
Ejemplares similares
-
A New Targeted Treatment for Lung Cancer Patients
por: Eaby-Sandy, Beth
Publicado: (2012) -
Swelling and Erythema of the Lower Extremities
por: Eaby-Sandy, Beth
Publicado: (2016) -
Systemic Treatments for Lung Cancer Patients Receiving Hemodialysis
por: Leung, Tzewah V., et al.
Publicado: (2018) -
Dermatologic Toxicities in Epidermal Growth Factor Receptor and Multikinase Inhibitors
por: Eaby-Sandy, Beth, et al.
Publicado: (2012) -
Plasma Osteopontin Is a Useful Diagnostic Biomarker for Advanced Non-Small Cell Lung Cancer
por: Han, Seon-Sook, et al.
Publicado: (2013)